Keryx drug improves phosphorus, iron in kidney patients: trial

July 24, 2014 11:58 PM

4 0

(Reuters) - A pivotal trial of Keryx Biopharmaceuticals Inc's experimental drug Zerenex showed that it improved levels of serum phosphorus and iron in patients on kidney dialysis, according to results published on Thursday.

The trial involved 441 patients, according to the Journal of the American Society of Nephrology, which published the results.

Read more

To category page